Akute Phase Reaktion nach kardiopulmonaler ReanimationAlbrecht Reinicke151.161.1.11.1.2781.291.31.3.11.3.210111.4121.4.113141.4.2151.4.31.51617181.5.1191.5.21.5.31.5.4201.5.51.5.61.5.7211.61.6.1221.6.2231.724456#4161.7.1251.7.21.7.3262273283.1293.2303.33.3.13.3.2313.3.3323.3.43.3.5333.3.63.4343.53.5.1353.5.2363.5.33.5.43.5.5373.64384.139404.1.141518#3714.1.242500#2604.1.343380#2604.1.4444.1.54.1.6377#2184.1.7454.1.84.1.94.2464.2.14.2.2474.2.34.2.4484.2.54.3494.3.1548#37150500#2604.3.24.3.351372#2614.44.4.1524.4.253501#3714.4.354515#3714.4.455513#3714.4.556516#3714.4.6575585.15.1.159605.1.25.1.35.1.4615.1.562635.25.2.15.2.2645.3655.3.1665.3.2675.3.3685.3.45.3.5695.3.6705.3.7715.3.85.4725.4.173745.4.2755.4.3765.4.4775.4.55.4.6787980480#26068182 Literatur8384858687888990919293949596979899DanksagungErklärungdeInhaltsverzeichnisHilfe Literatur [1]Negovsky, Vladimir A.: Postresuscitation disease, Critical Care Medicine 16 (1988) 942-946. [2]Negovsky, Vladimir A., Gurvitch, Alexander M.: Post-resuscitation disease - a new nosological entity. Its reality and significance, Resuscitation 30 (1995) 23-27. [3]Safar, Peter: Resuscitation from clinical death: Pathophysiologic limits and therapeutic potentials, Critical Care Medicine 16 (1988) 923-941. [4]Cerchiari, E.L.: The postresuscitation syndrome, Minerva Anestesiologica 60 (1994) 563-566. [5]Hotchkiss, Richard S., Karl, Irene E.: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis, Journal of the American Medical Association 267 (1992) 1503-1510. [6]Wenger, Roland H., Rolfs, Andreas, Marti, Hugo H., Bauer, Christian, Gassmann, Max: Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line, Journal of Biological Chemistry 270 (1995) 27865-27870. [7]1985 National Conference on Cardiopulmonary Resuscitation and Emergency Cardiac Care: Standards and Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC), Journal of the American Medical Association 255 (1986) 2905-2985. [8]Hofgärtner. F., Messelken, M., Stebich, M., Milewski, P., Sigel, H.: Präklinische Reanimation - Welche Faktoren beeinflussen den Langzeitverlauf ?, Deutsche Medizinische Wochenschrift 120 (1995) 1267-1272. [9]Sterz, Fritz, Janata, Karin, Kürkciyan, Istepan, Müllner, Markus, Malzer, Reinhard, Schreiber, Wolfgang: Possibilities of Brain Protection with Tirilazad after Cardiac Arrest, Seminars in Thrombosis and Hemostasis 22 (1996) 105-112. [10]Bergmann, H.: Die wissenschaftliche Basis der kardiopulmonalen und zerebralen Reanimation, Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 27 (1992) 196-204. [11]Stiell, Ian G., Wells, George A., Field, Brian J., Spaite, Daniel W., De Maio, Valerie J., Ward, Roxanne, Munkley, Douglas P., Lyver, Marion B., Luinstra, Lorraine G., Campeau, Tony, Maloney, Justin, Dagnone, Eugene: Improved Out-of-Hospital Cardiac Arrest Survival Through the Inexpensive Optimization of an Existing Defibrillation Program, Journal of the American Medical Association 281 (1999) 1175-1181. [12]Cobb, Leonard A., Fahrenbruch, Carol E., Walsh, Thomas R., Copass, Michael K., Olsufka, Michele, Breskin, Maryann, Hallstrom, Alfred P.: Influence of Cardiopulmonary Resuscitation Prior to Defibrillation in Patients With Out-of-Hospital Ventricular Fibrillation, Journal of the American Medical Association 281 (1999) 1182-1188. [13]Schwid, Howard A., Rooke, G. Alec, Ross, Brian K., Sivarajan, Murali: Use of a computerized advanced cardiac life support simulator improves retention of advanced cardiac life support guidelines better than a textbook review, Critical Care Medicine 27 (1999) 821-824. [14]Pepe, Paul E., Abramson, Norman S., Brown, Charles G.: ACLS - Does it really work ?, Annals of Emergency Medicine 23 (1994) 1037-1041. [15]Torres, Norman E., White, Roger D.: Current Concepts in Cardiopulmonary Resuscitation, Journal of Cardiothoracic and Vascular Anesthesia 11 (1997) 391-407. [16]Safar, Peter: Effects of the postresuscitation syndrome on cerebral recovery from cardiac arrest, Critical Care Medicine 13 (1985) 932-935. [17]Safar, Peter: Cerebral Resuscitation After Cardiac Arrest: Research Initiatives and Future Directions, Annals of Emergency Medicine 22 (1993) 324-349. [18]Berek, Klaus, Jeschow, Mario, Aichner, Franz: The Prognostication of Cerebral Hypoxia after Out-of-Hospital Cardiac Arrest in Adults, European Neurology 37 (1997) 135-145. [19]Chamberlain, Douglas, Cummins, Richard O., Abramson, N., Allen, Mervyn, Baskett, Peter, Becker, Lance, Bossaert, Leo, Delooz, Herman, Dick, Wolfgang, Eisenberg, Mickey, Evans, Thomas, Holmberg, Stig, Kerber, Richard, Mullie, Arsene, Ornato, Joseph P., Sandoe, Eric, Skulberg, Andreas, Tunstall-Pedoe, Hugh, Swanson, Richard, Thies, William: Recommended guidelines for uniform reporting of data from out-of-hospital cadiac arrest: the 'Utstein style', Resuscitation 22 (1991) 1-26. [20]Schörkhuber, Waltraud, Kittler, Harald, Sterz, Fritz, Behringer, Wilhelm, Holzer, Michael, Frossard, Martin, Spitzauer, Susanne, Laggner, Anton N.: Time course of serum neuron-specific enolase - A predictor of neurological outcome in patients resuscitated from cardiac arrest, Stroke 30 (1999) 1598-1603. [21]Rogove, Herbert J., Safar, Peter, Sutton-Tyrrell, Kim, Abramson, Norman S.: Old age does not negate good cerebral outcome after cardiopulmonary resuscitation, Critical Care Medicine 23 (1995) 18-25. [22]Bassetti, C., Bomio, Fulvio, Mathis, Johannes, Hess, Christian W.: Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients, Journal of Neurology, Neurosurgery, and Psychiatry 61 (1996) 610-615. [23]Neumann, A., Schneider, K., Schuster, A., Waydhas, Ch.: Reanimation im Notarztwagen - Welche Faktoren die Überlebensrate beeinflussen, Notfallmedizin 16 (1990) 838-847. [24]Juchems, R., Jacob, E., Frese, W., Roth, H.J.: Kardiopulmonale Reanimation: Vergleich der Erfolgsquoten der prä- und intrahospital begonnenen Reanimationen, Intensivmedizin 25 (1988) 420-424. [25]Rozenbaum, Eliezer A., Shenkman, Louis: Predicting outcome of inhospital cardiopulmonary resuscitation, Critical Care Medicine 16 (1988) 583-586. [26]Cobb, Leonard A., Weaver, Douglas W., Fahrenbruch, Carol E., Hallstrom, Alfred P., Copass, Michael K.: Community-Based Interventions for Sudden Cardiac Death, Circulation 85 (1992) I-98-I-102. [27]Eisenberg, Mickey S., Horwood, Bruce T., Cummins, Richard O., Reynolds-Haertle, R., Hearne, Thomas R.: Cardiac Arrest and Resuscitation: A Tale of 29 Cities, Annals of Emergency Medicine 19 (1990) 179-186. [28]Becker, Lance B., Ostrander, May Pat, Barrett, John, Kondos, George T: Outcome of CPR in a Large Metropolitan Area - Where are the Survivors ?, Annals of Emergency Medicine 20 (1991) 355-361. [29]Peterson, Michael W., Schwartz, David A., Moseley, Pope L.: Outcome after Cardiopulmonary Resuscitation in a Medical Intensive Care Unit, Chest 100 (1991) 168-174. [30]Grubb, N.R., Elton, R.A., Fox, K.A.A.: In-hospital mortality after out-of-hospital cardiac arrest, Lancet 346 (1995) 417-421. [31]Taffet, George E., Teasdale, Thomas A., Luchi, Robert J.: In-Hospital Cardiopulonary Resuscitation, Journal of the American Medical Association 260 (1988) 2069-2072. [32]Thel, Mark C., O’Connor, Christopher M.: Cardiopulmonary resuscitation: Historical perspective to recent investigations, American Heart Journal 137 (1999) 39-48. [33]Tuchschmidt, James A., Mecher, Carter E.: Predictors of Outcome from Critical Illness - Shock and Cardiopulmonary Resuscitation, Critical Care Clinics 10 (1994) 179-195. [34]Takino, M., Okada, Y.: Hyperthermia following cardiopulmonary resuscitation, Intensive Care Medicine 17 (1991) 419-420. [35]Müllner, Markus, Sterz, Fritz, Binder, Michael, Schreiber, Wolfgang, Deimel, Alexander, Laggner, Anton N.: Blood Glucose Concentration After Cardiopulmonary Resuscitation Influences Functional Neurological Recovery in Human Cardiac Arrest Survivors, Journal of Cerebral Blood Flow and Metabolism 17 (1997) 430-436. [36]Gleadle, Jonathan M., Ratcliffe, Peter J.: Hypoxia and the regulation of gene expression, Molecular Medicine Today 4 (1998) 122-129. [37]Vaangenes, Per, Ginsberg, Myron, Ebmeyer, Uwe, Ernster, Lars, Fischer, Matthias, Gisvold, Sven-Erik, Gurvitch, Alexander, Hossmann, Konstantin A., Nemoto, Edwin M., Radovsky, Ann, Severinghaus, John W., Safar, Peter, Schlichtig, Robert, Sterz, Fritz, Tonnessen, Tor, White, Robert J., Xiao, Feng, Zhou, Yuan: Cerebral resuscitation from cardiac arrest: Pathophysiologic mechanisms, Critical Care Medicine 24 (1996) S57-S68. [38]Ba, Zheng F.,Wang, Ping, Koo, Douglas J., Cioffi, William G., Bland, Kirby I., Chaudry, Irshad H.: Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock, Critical Care Medicine 28 (2000) 2837-2842. [39]Erslev, A.J.: Erythropoietin, New England Journal of Medicine 324 (1991) 1339-1344. [40]Guillemin, Karen, Krasnow, Mark A.: The hypoxic response - huffing and HIFing, Cell 89 (1997) 9-12. [41]Gassmann, Max, Wenger, Roland H.: Hif-1, a mediator of the molecular response to hypoxia, News in physiological sciences 12 (1997) 214-218. [42]Jiang, Bing-Hua, Semenza, Gregg L., Bauer, Christian, Marti, Hugo H.: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension, American Journal of Physiology 271 (1996) C1172-1180. [43]James, J. Howard, Luchette, Fred A., McCarter, Freda D., Fischer, Josef E.: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis, Lancet 354 (1999) 505-08. [44]Bone, Roger C., Balk, Robert A., Cerra, Frank B., Dellinger, R. Phillip, Fein, Alan M., Knaus, William A., Schein, Roland M.H., Sibbald, William J. (The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine): Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest 101 (1992) 1644-1655. [45]Geppert, Alexander, Zorn, Gerlinde, Karth, Georg Delle, Haumer, Markus, Gwechenberger, Marianne, Koller-Strametz, Jeanette, Heinz, Gottfried, Huber, Kurt, Siostrzonek, Peter: Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation, Critical Care Medicine 28 (2000) 2360-2365. [46]Granger, D.Neil: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury, American Journal of Physiology 255 (1988) H1269-H1275. [47]Shreeniwas, R., Koga, S., Karakurum, M., Pinsky, D., Kaiser, E., Brett, J., Wolitzky, B.A., Norton, C., Plocinski, J., Benjamin, W., Burns, D.K., Goldstein, A., Stern, D.: Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface, Journal of Clinical Investigation 90 (1992) 2333-2339. [48]Saikumar, Pothana, Dong, Zheng, Weinberg, Joel M., Venkatachalam, M.A.: Mechanisms of cell death in hypoxia/reoxygenation injury, Oncogene 17 (1998) 3341-3349. [49]Buchman, Timothy G., Cabin, Deborah E., Vickers, Selwyn, Deutschman, Clifford S., Delgado, Elsa, Sussman, Marc M., Bulkley, Gregory B.: Molecular biology of circulatory shock. Part II. Expression of four groups of hepatic genes is enhanced after resuscitation from cardiogenic shock, Surgery 108 (1990) 559-566. [50]Böttiger, Bernd W., Motsch, Johann, Braun, Volker, Martin, Eike, Kirschfink, Michael: Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans, Critical Care Medicine 30 (2002) 2473-2480. [51]Hoek, Terry L. Vanden: Preconditioning and postresuscitation injury, Critical Care Medicine 30 (2002) S172-175. [52]Willam, Carsten, Schindler, Ralf, Frei, Ulrich, Eckardt, Kai-Uwe: Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells, Amercian Journal of Physiology 273 (1999) H2044-H2052. [53]Kushner, Irving: The phenomenon of the acute phase response, Annals of the New York Academy of Sciences 389 (1982) 39-48. [54]Baumann, Heinz, Gauldie, Jack: The acute phase response, Immunology Today 15 (1994) 74-80. [55]Raynes, John G.: The acute phase response, Biochemical Society Transactions 22 (1994) 69-74. [56]Fearon, Douglas T., Locksley, Richard M.: The instructive role of innate immunity in the acquired immune response, Science 272 (1996) 50-54. [57]Moshage, Han: Cytokines and the hepatic acute phase response, Journal of Pathology 181 (1997) 257-266. [58]Ramadori, G., Christ, B.: Cytokines and the Hepatic Acute-Phase Response, Seminars in Liver Disease 19 (1999) 141-155. [59]Koj, Aleksander: Initiation of acute phase response and synthesis of cytokines, Biochimica et Biophysica Acta 1317 (1996) 84-94. [60]Perlmutter, David H., Dinarello, Charles A., Punsal, Patricia I., Colten, Harvey R.: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression, Journal of Clinical Investigation 78 (1986) 1349-1354. [61]Fantuzzi, Giamila, Dinarello, Charles A.: The inflammatory response in interleukin-1 beta-deficient mice: Comparison with other cytokine-related knock-out mice, Journal of Leukocyte Biology 59 (1996) 489-493. [62]Kopf, Manfred, Baumann, Heinz, Freer, Giulia, Freudenberg, Marina, Lamers, Marinus, Kishimoto, Tadamitsu, Zinkernagel, Rolf, Bluethmann, Horst, Köhler, Georges: Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature 368 (1994) 339-342. [63]Trautwein, C., Böker, K., Manns, M.P.: Hepatocyte and immune system: acute phase reaction as a contribution to early defense mechanisms, Gut 35 (1994) 1163-1166. [64]Pober, Jordan S.: Cytokine-mediated activation of vascular endothelium, American Journal of Pathology 133 (1988) 426-433. [65]Ebersole, Jeffrey L., Cappelli, David: Acute-phase reactants in infections and inflammatory diseases, Periodontology 23 (2000) 19-49. [66]Papanicolau, Dimitris A., Wilder, Ronald L., Manolagas, Stavros C., Chrousos, George P.: The pathophysiologic roles of interleukin-6 in human diseases, Annals of Internal Medicine 128 (1998) 127-137. [67]Erdogan, Okan, Öngen, Zeki: The importance of acute phase proteins in acute coronary syndromes, American Journal of Cardiology 79 (1997) 1439-1440. [68]Chrousos, George P.: The Hypothalamic-Pituitary-Adrenal Axis and Immune-Mediated Inflammation, New England Journal of Medicine 332 (1995) 1351-1362. [69]Trey, Joan E., Kushner, Irving: The acute phase response and the hematopoietic system: the role of cytokines, Critical Reviews in Oncology/Hematology 21 (1995) 1-18. [70]Kushner, Irving: Regulation of the acute phase response by cytokines, Perspectives in Biology and Medicine 36 (1993) 611-622. [71]Suffredini, Anthony F., Fantuzzi, Giamila, Badolato, Raffaele, Oppenheim, Joost J., O'Grady, Naomi P.: New insights into the biology of the acute phase response, Journal of Clinical Immunology 19 (1999) 203-214. [72]Mizock, Barry A.: Alterations in carbohydrate metabolism during stress: A review of the literature, American Journal of Medicine 98 (1995) 75-84. [73]Koj, Aleksander : Termination of Acute-Phase Response: Role of Some Cytokines and Anti-Inflammatory Drugs, General Pharmacology 31 (1998) 9-18. [74]Heinrich, Peter C., Castell, Jose V., Andus, Tilo: Interleukin-6 and the acute phase response, Biochemical Journal 265 (1990) 621-636. [75]Marinkovic, Sanja, Jahreis, Gerald P., Wong, Gordon G., Baumann, Heinz: IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo, Journal of Immunology 142 (1989) 808-812. [76]Cucianu, M., Plesca, Luminita, Bodizs, G., Colhon, D., Brudasca, Ioana: Acute phase reaction and the hemostatic balance, Romanian Journal of Internal Medicine 34 (1996) 13-18. [77]Dandona, Paresh, Nix, David, Wilson, Michael F., Aljada, Ahmad, Love, John, Assicot, Marcel, Bohoun, Claude: Procalcitonin Increase after Endotoxin Injection in Normal Subjects, Journal of Clinical Endocrinology and Metabolism 79 (1994) 1605-1608. [78]Tilg, H., Dinarello, C.A., Mier, J.W.: IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators, Immunology Today 18 (1997) 428-432. [79]Feldmann, Gerard, Scoazec, Jean Yves, Racine, Lorraine, Bernuau, Dominique: Functional hepatocellular heterogenity for the production of plasma proteins, Enzyme 46 (1992) 139-154. [80]Jungermann, Kurt, Katz, Norbert: Functional Specialization of Different Hepatocyte Populations, Physiological Reviews 69 (1989) 708-764. [81]Gabay, Cem, Kushner, Irving: Acute-Phase Proteins and Other Systemic Responses to Inflammation, New England Journal of Medicine 340 (1999) 448-454. [82]Pannen, Benedikt H.J., Robothan, James L.: The Acute-Phase Response, New Horizons 3 (1995) 183-196. [83]Kalmovarian, Nuanthip, Friedrichs, William E., O’Brien, Houston V., Linehan, Leslie A., Bowman, B.H., Yang, Funmei: Extrahepatic expression of plasma protein genes during inflammation, Inflammation 15 (1991) 369-379. [84]Mackiewicz, Andrzej, Speroff, Theodore, Ganapathi, Mahrukh K., Kushner, Irving: Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines, Journal of Immunology 146 (1991) 3032-7. [85]Schultz, Duane R., Arnold, Patricia I.: Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen, Seminars in Arthritis and Rheumatism 20 (1990) 129-147. [86]Szalai, Alexander J., van Ginkel, Frederik W., Wang, Yue, McGhee, Jerry R., Volanakis, John E.: Complement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-Component, Journal of Immunology 165 (2000) 1030-1035. [87]Maury, C.P.J.: Comparative study of serum amyloid A protein and C-reactive protein in disease, Clinical Science 68 (1985) 233-238. [88]Morley, John J., Kushner, Irving: Serum C-reaktive protein levels in disease, Annals of the New York Academy of Sciences 389 (1982) 406-418. [89]Nijsten, Maarten W.N., Olinga, Peter, The, T. Hauw, de Vries, Elisabeth G.E., Koops, Heimen Schraffordt, Groothuis, Geny M.M., Limburg, Pieter C., ten Duis, Henk J., Moshage, Han, Hoekstra, Harald J., Bijzet, J., Zwaveling, Jan H.: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro, Critical Care Medicine 28 (2000) 458-461. [90]Vigushin, David M., Pepys, Mark B., Hawkins, Philip N.: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease, Journal of Clinical Investigation 91 (1993) 1351-1357. [91]Macintyre, Stephen S.: C-Reactive Protein, Methods in Enzymology 163 (1988) 383-399. [92]Szalai, Alexander J., Agrawal, Alok, Greenhough, Trevor J., Volanakis, John E.: C-Reactive Protein: Structural Biology and Host Defense Function, Clinical Chemistry and Laboratory Medicine 37 (1999) 265-270. [93]Xu, Luoling, Badolato, Raffaele, Murphy, William J., Longo, Dan L., Anver, Miriam, Hale, Shirley, Oppenheim, Joost J., Wang, Ji Ming: A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion., Journal of Immunology 155 (1995) 1184-1190. [94]Marhaug, G., Dowton, S.B.: Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid, Baillère's Clinical Rheumatology 8 (1994) 553-573. [95]Benditt, Earl P., Eriksen, Nils, Meek, Rick L.: Serum Amyloid A Protein, Methods in Enzymology 163 (1988) 510-523. [96]Badolato, Raffaele, Wang, Ji Ming, Murphy, William J., Lloyd, Andrew R., Michiel, Dennis F., Bausserman, Linda L., Kelvin, David J., Oppenheim, Joost J.: Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes, Journal of Experimental Medicine 180 (1994) 203-209. [97]Arnaud, Phillipe, Miribel, Laurent, Roux, Anne Francoise: Alpha1-Acid Glycoprotein, Methods in Enzymology 163 (1988) 418-430. [98]Bowman, Barbara H., Barnett, Don R., Lum, Jean B., Yang, Funmei: Haptoglobin, Methods in Enzymology 163 (1988) 452-474. [99]D’Armiento, Jeanine, Dalal, Seema S., Chada, Kiran: Tissue, temporal and inducible expression pattern of haptoglobin in mice, Gene 195 (1997) 19-27. [100]Arnaud, Phillipe, Chapuis-Cellier, Colette: Alpha1-Antitrypsin, Methods in Enzymology 163 (1988) 400-418. [101]Assicot, Marcel, Gendrel, Dominique, Carsin, Herve, Raymond, Josette, Guilbaud, Jean, Bohuon, Claude: High serum procalcitonin concentrations in patients with sepsis and infection, Lancet 341 (1993) 515-518. [102]Gendrel, D., Bohuon, C.: Procalcitonin, a marker of bacterial infection, Infection 25 (1997) 133-134. [103]Russwurm, Stefan, Wiederhold, Matthias, Oberhoffer, Mathias, Stonans, Ilmars, Zipfel, Peter F., Reinhart, Konrad: Molecular Aspects and Natural Source of Procalcitonin, Clinical Chemistry and Laboratory Medicine 37 (1999) 789-797. [104]Nylen, Eric S., Whang, Kevin T., Snider, Richard H., Steinwald, Paul M., White, Jon C., Becker, Kenneth L.: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis, Critical Care Medicine 26 (1998) 1001-1006. [105]Steinwald, Paul M., Whang, Kevin T., Becker, Kenneth L., Snider, Richard H., Nylen, Eric S., White, Jon C.: Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis, Critical Care 3 (1999) 11-16. [106]Marik, Paul E.: Definition of sepsis: Not quite time to dump SIRS?, Critical Care Medicine 30 (2002) 706-708. [107]Whang, Keven T., Vath, Steven D., Becker, Kenneth L., Snider, Richard H., Nylen, Eric S., Muller, Beat, Li, Qichang, Tamarkin, Lawrence, White, Jon C.: Procalcitonin and proinflammatory cytokine interactions in sepsis, Shock 14 (2000) 73-78. [108]Rothenburger, Markus, Markewitz, Andreas, Lenz, Thomas, Kaulbach, Hans-Georg, Marohl, Klaus, Kuhlmann, Wolf-Dieter, Weinhold, Christian: Detection of Acute Phase Response and Infection. The Role of Procalcitonin and C-Reactive Protein., Clinical Chemistry and Laboratory Medicine 37 (1999) 275-279. [109]Oberhoffer, M., Karzai, W., Meier-Hellmann, A., Reinhart, K.: Procalcitonin - Ein neuer diagnostischer Parameter bei schweren Infektionen und Sepsis, Anaesthesist 47 (1998) 581-587. [110]Gerard, Y., Hober, D., Petitjean, S., Assicot, M., Bohoun, C., Mouton, Y., Wattre, P.: High Serum Procalcitonin Level in a 4-Year-Old Liver Transplant Recipient with a Disseminated Candidiasis, Infection 23 (1995) 310-311. [111]Davis, T.M.E., Assicot, M., Bohoun, C., St John, A., Li, Guo Qiao, Anh, Trinh Kim: Serum procalcitonin concentrations in acute malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (1994) 670-671. [112]Yan, Shi Fang, Tritto, IsabelIa, Pinsky, David, Liao, Hui, Huang, James, Fuller, Gerald, Brett, Jerold, May, Lester, Stern, David: Induction of interleukin 6 (IL-6) by hypoxia in vascular cells - Central role of the binding site for nuclear factor-IL-6, Journal of Biological Chemistry 270 (1995) 11463-11471. [113]Rolfs, Andreas, Kvietikova, Ivica, Gassmann, Max, Wenger, Roland H.: Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1, Journal of Biological Chemistry 272 (1997) 20055-20062. [114]Simpson, R.J.: Effect of hypoxic exposure on iron absorption in heterozygous hypotransferrinaemic mice, Annals of Hematology 65 (1992) 260-264. [115]Klausen, Tom, Olsen, Niels Vidiendal, Poulson, Troels Dirch, Richalet, Jean-Paul, Pedersen, Bente Klarlund: Hypoxemia increases serum interleukin-6 in humans, European Journal of Applied Physiology and Occupational Physiology 76 (1997) 480-482. [116]Klokker, M., Kharazmi, A., Galbo, H., Bygbjerg, I., Pedersen, B.K.: Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines, Journal of Applied Physiology 74 (1993) 1100-1106. [117]Hartmann, G., Tschöp, M., Fischer, R., Bidlingmaier, C., Riepl, R., Tschöp, K., Hautmann, H., Endres, S., Toepfer, M.: High Altitude increases circulating Interleukin-6, Interleukin-1 Receptor Antagonist and C-reactive Protein, Cytokine 12 (2000) 246-252. [118]Osterloh, Kurt R.S., Simpson, R.J., Snape, S., Peters, T.J.: Intestinal Iron Absorption and Mucosal Transferrin in Rats Subjected to Hypoxia, Blut 55 (1987) 421-431. [119]Cabin, Deborah E., Buchman, Timothy G.: Molecular biology of circulatory shock. Part III. Human hepatoblastoma (HepG2) cells demonstrate two patterns of shock-induced gene expression that are independent, exclusive, and prioritized, Surgery 108 (1990) 902-912. [120]Buchman, Timothy G., Cabin, Deborah E., Porter, John M., Bulkley, Gregory B.: Change in hepatic gene expression after shock/resuscitation, Surgery 106 (1989) 283-291. [121]Men, Zhi Hong, Dyer, Kevin, Billiar, Timothy R., Tweardy, David J.: Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock, American Journal of Physiology 280 (2001) C343-C351. [122]Rosenson, Robert S.: Myocardial injury: the acute phase response and lipoprotein metabolism, Journal of the American College of Cardiology 22 (1993) 933-940. [123]Noma, A., Abe, A., Maeda, S., Seishima, M., Makino, K., Yano, Y., Shimokawa, K.: Lp(a): an acute-phase reactant? , Chemistry and Physics of Lipids 67 (1994) 411-417. [124]Lecharny, Jean-Baptiste, Khater, Daniele, Bronchard, Régis, Philip, Ivan, Durand, Geneviève, Desmonts, Jean-Marie, Dehoux, Monique: Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery, Critical Care Medicine 29 (2001) 323-325. [125]Berendes, Elmar, Möllhoff, Thomas, Van Aken, Hugo, Erren, Michael, Deng, Mario C., Loick, Heinz Michael: Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass, Critical Care Medicine 25 (1997) 1527-1533. [126]Whicher, John, Biasucci, Luigi, Rifai, Nader: Inflammation, the Acute Phase Response and Atherosclerosis, Clinical Chemistry and Laboratory Medicine 37 (1999) 495-503. [127]Gaussorgus, P., Gueugniaud, P.-Y., Vedrinne, J.-M., Salord, F., Mercatello, A., Robert, D.: Bacteremia following cardiac arrest andcardiopulmonary resuscitation, Intensive Care Medicine 14 (1988) 575-577. [128]Bonten, M.J.M.: Controversies on diagnosis and prevention of ventilator associated pneumonia, Diagnostic Microbiology and Infectious Disease 34 (1999) 199-204. [129]Muckart, David J. J., Bhagwanjee, Satish: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients, Critical Care Medicine 25 (1997) 1789-1795. [130]Ugarte, Hector, Silva, Eliezer, Mercan, Dany, De Mendonca, Arnaldo, Vincent, Jean-Louis: Procalcitonin used as a marker of infection in the intensive care unit, Critical Care Medicine 27 (1999) 498-504. [131]Reinhart, K., Karzai, W., Meisner, M.: Procalcitonin as a marker of the systemic inflammatory response to infection, Intensive Care Medicine 26 (2000) 1193-1200. [132]Eberhard, O.K., Haubitz, M., Brunkhorst, F.M., Kliem, V., Koch, K.M., Brunkhorst, R.: Usefulness of Procalcitonin for Differentiation between Activity of Systemic Autoimmune Disease (Systemic Lupus Erythematodes / Systemic Antineutrophil Cytoplasmic Antibody-Associated Vasculitis) and Invasive Bacterial Infection, Arthritis & Rheumatism 40 (1997) 1250-1256. [133]Brunkhorst, Frank M., Eberhard, Oliver K., Brunkhorst, Reinhard: Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin, Critical Care Medicine 27 (1999) 2172-2176. [134]Kuse, Ernst-R., Langefeld, Iris, Jaeger, Karsten, Kulpmann, Wolf-R.: Procalcitonin in fever of unknown origin after liver transplantation - A variable to differentiate acute rejection from infection, Critical Care Medicine 28 (2000) 555-559. [135]Whang, Kevin T., Steinwald, Paul M., White, Jon C., Nylen, Eric S., Snider, Richard H., Simon, Gary L., Goldberg, Robin L., Becker, Kenneth L.: Serum calcitonin precursors in sepsis and systemic inflammation, Journal of Clinical Endocrinology and Metabolism 83 (1998) 3296-301. [136]Müller, Beat, Becker, Kenneth L., Schächinger, Hartmut, Rickenbacher, Peter R., Huber, Peter R., Zimmerli, Werner, Ritz, Rudolf: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit, Critical Care Medicine 28 (2000) 977-983. [137]Meisner, M., Tschaikowsky, K., Palmaers, T., Schmidt, J.: Comparison of procalcitonin (PCT) and Creactive protein (CRP) plasma concentrations at different SOFA-scores during the course of sepsis and MODS, Critical Care 3 (1999) 45-50. [138]Gendrel, Dominique, Assicot, Marcel, Raymond, Josette, Moulin, Florence, Francoual, Christine, Badoual, Jean, Bohoun, Claude: Procalcitonin as a marker for the early diagnosis of neonatal infection, Journal of Pediatrics 128 (1996) 570-573. [139]Monneret, G., Labaune, J.M., Isaac, C., Bienvenu, F., Putet, G., Bienvenu, J.: Procalcitonin and C-reactive protein levels in neonatal infections, Acta Paediatrica 86 (1997) 209-212. [140]Gendrel, Dominique, Raymond, Josette, Coste, Joel, Moulin, Florence, Lorrot, Mathie, Guerin, Sylvie, Ravilly, Sophie, Lefevre, Herve, Royer, Catherine, Lacombe, Catherine, Palmer, Pierre, Bohuon, Claude: Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial vs. viral infections, Pediatric Infectious Disease Journal 18 (1999) 875-81. [141]Gendrel, Dominique, Raymond, Josette, Assicot, Marcel, Moulin, Florence, Iniguez, Jean-Luc, Lebon, Pierre, Bohoun, Claude: Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis, Clinical Infectious Diseases 24 (1997) 1240-1242. [142]Schwarz, Stefan, Bertram, Markus, Schwab, Stefan, Andrassy, Konrad, Hacke, Werner: Serum procalcitonin levels in bacterial and abacterial meningitis, Critical Care Medicine 28 (2000) 1828-32. [143]Rau, B., Steinbach, G., Baumgart, K., Gansauge, F., Grünert, A., Beger, H.G.: The clinical value of procalcitonin in the prediction of infected necrosis in pancreatitis, Intensive Care Medicine 26 (2000) S159-64. [144]Nylen, Eric S., Snider, Richard H., Thompson, Keith A., Rohatgi, Prashant, Becker, Kenneth, L.: Pneumonitis-Associated Hyperprocalcitoninemia, American Journal of the Medical Sciences 312 (1996) 12-18. [145]Eckardt, Kai-Uwe, Boutellier, Urs, Kurtz, Armin, Schopen, Michael, Koller, Erwin A., Bauer, Christoph: Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia, Journal of Applied Physiology 66 (1989) 1785-1788. [146]Veneman, T. F., van Dijk, G.W., Boereboom, F., Joore, H., Savelkoul, T. J. F.: Prediction of outcome after resuscitation in a case of electrocution, Intensive Care Medicine 24 (1998) 255-257. [147]Perdiz, Pilar, Wacher, Niels, Laredo-Sanchez, Fernando, Cherem, Jose Halabe, Lifshitz, Alberto: Circadian variation of human acute phase response, Archives of Medical Research 27 (1996) 157-163. [148]Clark, Geraldine H., Fraser, Callum G.: Biological variation of acute phase proteins, Annals of Clinical Biochemistry 30 (1993) 373-376. [149]Eckardt, K.-U., Kurtz, A., Hirth, P., Scigalla, P., Wieczorek, L., Bauer, C.: Evaluation of the stability of human erythropoietin in samples for radioimmunoassay, Klinische Wochenschrift 66 (1988) 241-245. [150]Karzai, W., Oberhoffer, M., Meier-Hellmann, A., Reinhart, K.: Procalcitonin - A New Indicator of the Systemic Response to Severe Infections, Infection 25 (1997) 329-334. [151]Brunkhorst, F.M., Wegscheider, K., Forycki, Z.F., Brunkhorst, R. : Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock, Intensive Care Medicine 26 (2000) S148-52. [152]Remskar, Mojca, Horvat, Matija, Hojker, Sergej, Noc, Marko: Procalcitonin in patients with acute myocardial infarction, Wiener Klinische Wochenschrift 114 (2002) 205-210. [153]Kushner, Irving, Rzewnicki, Debra L.: The acute phase response: General aspects, Baillère's Clinical Rheumatology 8 (1994) 513-530. [154]Fey, Georg H., Gauldie, J.: The Acute Phase Response of the Liver in Inflammation, Progress in Liver Diseases 9 (1990) 89-116. [155]Steel, Diana M., Whitehead, Alexander S.: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein, Immunology Today 15 (1994) 81-88. [156]Eckardt, Kai-Uwe, Kurtz, Armin, Bauer, Christian: Triggering of erythropoietin production by hypoxia is inhibited by respiratory and metabolic acidosis, American Journal of Physiology 258 (1990) R678-R683. [157]Ahsen, Nicolas von, Müller, Christian, Serke, Stefan, Frei, Ulrich, Eckardt, Kai-Uwe: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients, Critical Care Medicine 27 (1999) 2630-2639. [158]Lorentz, A., Eckardt, K.-U., Osswald, P.M., Kruse, C.: Perioperative plasma erythropoietin levels in hip arthroplasty, Annals of Hematology 68 (1994) 117-124. [159]Pavlicek, V., Marti, H.H., Grad, S., Gibbs, J.S.R., Kol, C., Wenger, R.H., Gassmann, M., Kohl, J., Maly, F.E., Oelz, O., Koller, E.A., Schirlo, C.: Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema, European Journal of Applied Physiology 81 (2000) 497-503. [160]Maes, Michael, Hendriks, Dirk, van Gastel, An, Demedts, Paul, Wauters, Annick, Neels, Hugo, Janca, Aleksandar, Scharpe, Simon: Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers, Psychoneuroendocrinology 22 (1997) 397-409. [161]Abel, J., Spannbrucker, N., Fandrey, J., Jelkmann, W.: Serum erythropoietin levels in patients with sepsis and septic shock, European Journal of Haematology 57 (1996) 359-363. [162]Ragsdale, D. Nicholas, Proctor, Kenneth G.: Acadesine and intestinal barrier function after hemorrhagic shock and resuscitation, Critical Care Medicine 28 (2000) 3876-3884. [163]Morris, Todd J., Dries, David J.: Gut protection: Why and how, Critical Care Medicine 29 (2001) 1636-1637. [164]Smith, Michael D., Supputtamongkol, Yupin, Chaowagul, Wipada, Assicot, Marcel, Bohuon, Claude, Petitjean, Sylvie, White, Nicholas, J.: Elevated Serum Procalcitonin Levels in Patients with Melioidosis, Clinical Infectious Diseases 20 (1995) 641-645. [165]Schröder, J., Staubach, K.-H., Zabel, P., Stüber, F., Kremer, B.: Procalcitonin as a marker of severity in septic shock, Langenbeck's Archives of Surgery 384 (1999) 33-38. [166]Cheval, C., Timsit, J. F., Garrouste-Orgeas, M., Assicot, M., de Jonghe, B., Misset, B., Bohoun, C., Carlet, J.: Procalcitonin is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients, Intensive Care Medicine 26 (2000) S153-158. [167]Dofferhoff, Anthonius S.M., Bom, Victor J.J., de Vries-Hospers, Hilly G., van Ingen, Jan, van der Meer, Jan, Hazenberg, Bouke P.C., Mulder, Paula O.M., Weits, Jan: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans, Critical Care Medicine 20 (1992) 185-192. [168]Wanner, Guido A., Keel, Marius, Steckholzer, Ursula, Beier, Wilfried, Stocker, Reto, Ertel, Wolfgang: Relationship between pocalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients, Critical Care Medicine 28 (2000) 950-957. [169]De Werra, Isabelle, Jaccard, Christian, Corradin, Sally Betz, Chiolero, Rene, Yersin, Bertrand, Gallati, Harald, Assicot, Marcel, Bohuon, Claude, Baumgartner, Jean-Daniel, Glausner, Michel P., Heumann, Didier: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia, Critical Care Medicine 25 (1997) 607-613. [170]Olaison, Lars, Hogevik, Harriet, Alestig, Kjell: Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis, Archives of Internal Medicine 157 (1997) 885-892. [171]Yentis, S.M., Soni, N., Sheldon, J.: C-reactive Protein as an indicator of resolution of sepsis in the intensive care unit, Intensive Care Medicine 21 (1995) 602-605. [172]Whicher, J.T., Evans, S.W.: Acute phase proteins, Hospital Update 15 (1990) 899-905. [173]Reny, Jean-Luc, Vuagnat, Albert, Ract, Catherine, Benoit, Marie-Odile, Safar, Michel, Fagon, Jean-Yves: Diagnosis and follow-up of infections in intensive care patients, Critical Care Medicine 30 (2002) 529-535.